ADBiotech Co., Ltd. (KOSDAQ:179530)

South Korea · Delayed Price · Currency is KRW

2,105.00

-25.00 (-1.17%)

At close: Oct 16, 2026

Market Cap	56.73B +45.8%
Revenue (ttm)	12.57B -0.8%
Net Income	-3.53B
EPS	-207.76
Shares Out	26.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,141
Open	2,260.00
Previous Close	2,130.00
Day's Range	2,040.00 - 2,260.00
52-Week Range	1,300.00 - 4,100.00
Beta	0.27
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2000

Employees 67

Stock Exchange KOSDAQ

Ticker Symbol 179530

Full Company Profile

Financial Performance

In 2025, ADBiotech's revenue was 12.90 billion, an increase of 15.81% compared to the previous year's 11.14 billion. Losses were -3.30 billion, -58.45% less than in 2024.

Financial Statements